• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Tharimmune Appoints James Gordon Liddy as Key Strategic Advisor

    ACCESSWIRE

    Tharimmune Presents Positive Clinical Data Of TH104

    ACCESSWIRE

    Tharimmune Abstracts Accepted for DDW and EASL Conferences

    ACCESSWIRE

    Tharimmune Appoints Clay Kahler, Gary Stetz to Board of Directors

    ACCESSWIRE

    Tharimmune Advances TH104 for Prophylaxis Against Weaponized fentanyl

    ACCESSWIRE

    Tharimmune appoints Vincent LoPriore to Board of Directors

    ACCESSWIRE

    Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF

    ACCESSWIRE

    Tharimmune gets FDA nod for TH104 to prevent opioid depression

    #N/A

    Tharimmune Reports Positive Results for Oral Antibody TH023 Target

    ACCESSWIRE

    Tharimmune reports success with novel biologics using EpiClick

    ACCESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.